Search

Your search keyword '"Hino, Keisuke"' showing total 495 results

Search Constraints

Start Over You searched for: Author "Hino, Keisuke" Remove constraint Author: "Hino, Keisuke"
495 results on '"Hino, Keisuke"'

Search Results

1. Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation

2. New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease

8. New quantitative measurement system for M2BPGi reveals liver inflammation complicates liver cirrhosis diagnosis

9. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines

12. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial

13. A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial

16. A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial.

18. HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice

19. A case of protuberant lesion of the gallbladder for which FFT analysis may have been useful in determining benignity

21. Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy

22. Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis assay

23. A case of successful treatment with antiretroviral therapy for HIV in a patient with marked liver dysfunction

25. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma

31. Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C

32. Tu1310: NON-INVASIVE TESTS (NITS) FOR PREDICTING HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WITHOUT CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INDIVIDUAL PATIENT DATA AND AGGREGATE DATA

33. Transcatheter arterial chemoembolization therapy in combination strategy with lenvatinib in patients with unresectable hepatocellular carcinoma (TACTICS-L) in Japan: Final analysis.

35. Iron and liver cancer: an inseparable connection.

36. # 1076 Sofosbuvir in combination with ribavirin for 12 weeks achieves 97% sustained virologic response in Japanese patients with chronic genotype 2 hepatitis C infection

43. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial

47. Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.

50. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease

Catalog

Books, media, physical & digital resources